Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

New England Journal of Medicine

Volumn 322, Issue 18, 1990, Pages 1265-1271

  Storm, Tommy ^a   Thamsborg, Gorm ^a   Steiniche, Torben ^b   Genant, Harry K ^c   Sorensen, Ole Helmer ^a  

^a AMAGER HOSPITAL   (Denmark)

^b University Institute of Pathology Arhus   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID;

ARTICLE; BONE MASS; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; BONE AND BONES; BONE RESORPTION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; FRACTURES; HUMAN; MIDDLE AGE; MINERALS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; SPINAL INJURIES; SUPPORT, NON-U.S. GOV'T;

EID: 0025366467     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199005033221803     Document Type: Article

References (29)

1. Guncaga J, Lauffenburger T, Lentner C, et al. Diphosphonate treatment of Paget's disease of bone: a correlated metabolic, calcium kinetic and morphometric study. Horm Metab Res 1974; 6: 62–9.
2. Fleisch H. Diphosphonates: history and mechanisms of action. Metab Bone Dis Relat Res 1981; 3: 279–87.
3. Fleisch. Experimental basis for the use of bisphosphonates in Paget's disease of bone. Clin Orthop 1987; 217: 72–8.
4. Heaney RP, Saville PD. Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther 1976; 20: 593–604.
5. Anderson C, Cape RD, Crilly RG, Hodsman AB, Wolfe BM. Preliminary observations of a form of coherence therapy for osteoporosis. Calcif Tissue Int 1984; 36: 341–3.
6. Frost HM. Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop 1979; 143: 227–44.
7. Kr⊘lner B, Pors Nielsen S. Measurement of bone mineral content (BMC) of the lumbar spine. I. Theory and application of a new two-dimensional dualphoton attenuation method. Scand J Clin Lab Invest 1980; 40: 653–63.
8. Christiansen C, R⊘dbro P, Jensen H. Bone mineral content in the forearm measured by photon absorptiometry: principles and reliability. Scand J Clin Lab Invest 1975; 35: 323–30.
9. Ettinger B, Block JE, Smith R, Cummings SR, Harris ST, Genant HK. An examination of the association between vertebral deformities, physical disabilities and psychosocial problems. Maturitas 1988; 10: 283–96.
10. Richardson ML, Genant HK, Cann CE, et al. Assessment of metabolic bone diseases by quantitative computed tomography. Clin Orthop 1985; 195: 224–38.
11. Kivirikko KI, Laitinen O, Prockop DJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967; 19: 249–55.
12. Bordier P, Matrajt H, Miravet L, Hioco D. Mesure histologique de la masse et de la résorption des travées osseuses. Pathol Biol 1964; 12: 1238–43.
13. Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res 1969; 3: 211–37.
14. Meisen F, Meisen B, Mosekilde L, Bergmann S. Histomorphometric analysis of normal bone from iliac crest. Acta Pathol Microbiol Scand [A] 1978; 86: 70–81.
15. Eriksen EF, Meisen F, Mosekilde L. Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res 1984; 5: 235–42.
16. Eriksen EF, Gundersen HJ, Meisen F, Mosekilde L. Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res 1984; 5: 243–52.
17. Storm T, Thamsborg G, S⊘rensen OH, Lund B. The effects of etidronate therapy in postmenopausal osteoporotic women: preliminary results. In: Christiansen C, Johansen JS, Riis BJ, eds. Osteoporosis 1987: International Symposium on Osteoporosis, Denmark, 1987, Sept. 27-Oct. 2. Vol. 2. Copenhagen: Osteopress ApS, 1987:1172–6.
18. Pocock SJ. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics 1982; 38: 153–62.
19. Gruber HE, Ivey JL, Baylink DJ, et al. Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 1984; 33: 295–303.
20. Gennari C, Chierichetti SM, Bigazzi S, et al. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis. Curr Ther Res 1985; 38: 455–64.
21. Mazzuoli GF, Passen M, Gennari C, et al. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 1986; 38: 3–8.
22. Genant HK, Harris ST, Steiger P, Davey PF, Block JE. The effect of etidronate therapy in postmenopausal osteoporotic women: preliminary results. In: Christiansen C, Johansen JS, Riis BJ, eds. Osteoporosis 1987: International Symposium on Osteoporosis, Denmark, 1987, Sept. 27-Oct. 2. Vol. 2. Copenhagen: Osteopress ApS, 1987:1177–81.
23. Hodsman AB. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. Bone Miner 1989; 5: 201–12.
24. Parfitt AM. Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 1980; 4: 273–87.
25. Kanis JA. Gray RE. Long-term follow-up observations on treatment in Paget's disease of bone. Clin Orthop 1987; 217: 99–125.
26. Pacifici R, McMurtry C, Vered I, Rupich R, Avioli LV. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study. J Clin Endocrinol Metab 1988; 66: 747–53.
27. Hesch RD, Heck J, Delling G, et al. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDP: protocol of study I, osteoporosis trial Hannover. Klin Wochenschr 1988; 66: 976–84.
28. Fogelman I, Smith L, Mazess R, Wilson MA, Bevan JA. Absorption of oral diphosphonate in normal subjects. Clin Endocrinol (Oxf) 1986; 24: 57–62.
29. Kanis JA. Treatment of osteoporotic fracture. Lancet 1984; 1: 27–33.